Abbott Laboratories

Abbott Laboratories Beats on EPS, Stock Down 2.41%

Abbott Laboratories reported an EPS that slightly exceeded expectations, but the stock fell by 2.41% following the announcement. The lack of revenue data and guidance may have contributed to investor uncertainty, leading to the stock's decline despite the EPS beat.